Pharma Pulse 5/22/24: Effects of the FTC's Repeal of Non-Competes on Pharma Industry, Does Legalizing Cannabis Increase Adolescent Use? & more

Effects of the Federal Trade Commission's Repeal of Non-Compete Agreements on the Pharma Industry

Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry.

The Role of Pharmacogenomics in Reducing Racial Disparities in Pediatric AML Treatment Outcomes

A new study in JAMA Network Open suggests that disparities in outcomes between Black and White children with acute myeloid leukemia may be due to differences in pharmacogenomics, which is how genes affect drug responses.

Does Legalizing Cannabis Increase Adolescent Use? This Expert Found Mixed Results.

Contrary to expectation, a major study found that weed use among minors was lower in states where the drug was legal.

Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings

Incyte announced the expansion of its presence in Delaware with the acquisition of two buildings at 1100 North King Street and 1100 North French Street in downtown Wilmington. This acquisition marks Incyte’s fourth expansion in Delaware since establishing operations in Alapocas in 2014. The new buildings will allow the Company’s U.S.-based teams to be located together as they continue to deliver on their commitment to finding innovative solutions for patients with critical unmet medical needs.

Amanda Powers Han on LinkedIn:

Thank you very much, Pharmaceutical Executive for the important and engaging discussion!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs